NEUVOGEN
Live / Applied — Second extension granted (statement of use) (as of 25 Feb 2026)
What this means for you
Not registered yet, but its 25 Mar 2020 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88847538
- Mark type
- Stylized text
- Filed
- 25 Mar 2020
- Published for opposition
- 31 Dec 2024
- Attorney of record
- Bret J. Danow
Goods and services
- Class 005 — Pharmaceuticals: Vaccines
Owner
- NEUVOGEN, INC., SAN DIEGO, CA, US
- NEUVOGEN, INC., SAN DIEGO, CA, US
- ImmunoActiva, Inc., San Diego, CA, US
Prosecution history
- 25 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Feb 2026 — SOU EXTENSION 2 GRANTED
- 11 Feb 2026 — SOU EXTENSION 2 FILED
- 12 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 09 Feb 2026 — CORRECTED NOA E-MAILED
- 09 Feb 2026 — SOU EXTENSION 1 GRANTED
- 17 Aug 2025 — SOU EXTENSION 1 FILED
- 09 Feb 2026 — DIVISIONAL PROCESSING COMPLETE
- 18 Aug 2025 — DIVISIONAL REQUEST RECEIVED
- 27 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Aug 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 25 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 31 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Dec 2024 — PUBLISHED FOR OPPOSITION
- 25 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED